Quantifying the benefits of genomics is a key focus of the InGeNA Strategic Plan launched today. InGeNA has commenced a major project with Deloitte Access Economics to develop an evidence base to demonstrate the value of genomics to the economy, society and patient...
InGeNA will provide a united industry voice when it acts as the Industry Advisory Group to the Australian Genomics Health Alliance (Australian Genomics). InGeNA and Australian Genomics have agreed to collaborate and work together on sharing information and developing...
Realising the full potential of genomics to personalise healthcare is a compelling vision, but now the real work begins in how to implement it. InGeNA was established to help bring the vision of precision health to fruition, where Australian citizens are the...